A 12-mer repetitive antigenic epitope fromTrypanosoma cruziis a potential marker of therapeutic efficacy in chronic Chagas' disease
Author(s) -
Ana FernándezVillegas,
M. Carmen Thomas,
Bartolomé Carrilero,
Paola Lasso,
Adriana Egui,
Laura Murcia,
Manuel Segovia,
Carlos AlonsoMoreno,
Manuel Carlos López
Publication year - 2016
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkw090
Subject(s) - benznidazole , chagas disease , asymptomatic , trypanosoma cruzi , nifurtimox , immunology , medicine , cardiomyopathy , antigen , gastroenterology , biology , heart failure , parasite hosting , world wide web , computer science
The objective was to characterize a Trypanosoma cruzi repetitive amino acid sequence that can be used as a marker of therapeutic drug efficacy in patients with chronic Chagas' disease.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom